2014
Receipt of Prescription Contraception by Commercially Insured Women With Chronic Medical Conditions
DeNoble AE, Hall KS, Xu X, Zochowski MK, Piehl K, Dalton VK. Receipt of Prescription Contraception by Commercially Insured Women With Chronic Medical Conditions. Obstetrics And Gynecology 2014, 123: 1213-1220. PMID: 24807345, PMCID: PMC4169713, DOI: 10.1097/aog.0000000000000279.Peer-Reviewed Original ResearchConceptsChronic medical conditionsPrescription contraceptionChronic conditionsMedical conditionsCommunity-level socioeconomic statusAdministrative claims recordsTotal outpatient visitsInflammatory bowel diseaseSystemic lupus erythematosusCervical cancer screeningMultivariable logistic regressionChronic condition statusBowel diseaseLupus erythematosusOrder of prevalencePharmacy claimsPrimary outcomeOutpatient visitsRheumatoid arthritisAdverse outcomesCancer screeningUnplanned pregnancyObservational studyStudy populationInsured women
2011
Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation
Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, Coleman RE, Kraus VB. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proceedings Of The National Academy Of Sciences Of The United States Of America 2011, 108: 2088-2093. PMID: 21245324, PMCID: PMC3033282, DOI: 10.1073/pnas.1012743108.Peer-Reviewed Original ResearchConceptsIL-18OA severityIL-1βUric acidOA progressionSynovial fluid IL-1βCohort of subjectsKnee OA severityInnate immune systemKnee osteoarthritisBone scintigraphyNLRP3 inflammasomeOA pathologyInflammasome activationDanger signalsImmune systemOsteoarthritisRadiographsSeverityPotential involvementInflammasomeProgressionScintigraphyNLRP3Cytokines